Buscar
16/03/2026
TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and Therapeutic Advances
Portu, M, Balsa, M, Cotaina, M, Anguera, G, del Muro, XG, Algaba, F, Maroto, P. TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and Therapeutic Advances. Cancers. 2026; 18(6)DOI:10.3390/cancers18060958. PMID:41899560. IF:4.400(Q2/3D).
01/01/2025
Precision targeting of CXCR4+leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model.
Garcia-Leon, Annabel, Mendoza, Julian I, Rueda, Ariana, Alba-Castellon, Lorena, Nomdedeu, Josep F, Gallardo, Alberto, Sierra, Jorge, Garrido, Ana, Vazquez, Esther, Villaverde, Antonio, Mangues, Ramon, Unzueta, Ugutz, Casanova, Isolda. Precision targeting of CXCR4+leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2025; 192DOI:10.1016/j.biopha.2025.118573. PMID:. IF:(Q/D).
01/09/2024
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles
Parladé, E, García-Leon, A, Voltà-Durán, E, Unzueta, U, Mangues, R, Casanova, I, Villaverde, A, Váquez, E. Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2024; 202DOI:10.1016/j.ejpb.2024.114410. PMID:39004320. IF:4.300(Q1/2D).
01/12/2022
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera (vol 101, 2231, 2022)
Triguero, A, Pedraza, A, Perez-Encinas, M, Mata-Vazquez, MI, Velez, P, Fox, L, Gomez-Calafat, M, Garcia-Delgado, R, Gasior, M, Ferrer-Marin, F, Garcia-Gutierrez, V, Angona, A, Gomez-Casares, MT, Cuevas, B, Martinez, C, Perez, R, Raya, JM, Guerrero, L, Murillo, I, Bellosillo, B, Hernandez-Boluda, JC, Sanz, C, Alvarez-Larran, A. Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera (vol 101, 2231, 2022). ANNALS OF HEMATOLOGY. 2022; 101(12)DOI:10.1007/s00277-022-05005-4. PMID:36264368. IF:3.500(Q2/5D).
01/01/2026
Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular
Fernández-Luis, S, Bermúdez, A, San Segundo, LY, González, MB, Asensio, SM, Esquirol, A, García-Cadenas, I, Pascual, MJ, Herruzo, B, Salas, MQ, Alburquerque-Prieto, C, Viguria-Alegría, MC, Pérez, A, Hernani, R, Mas, MH, Villalba, M, Calvo, CM, Fabbri, N, González-Rodriguez, AP, Bailén, R, Tomás, LG, Maño, LG, Salinas, AS, Calbacho, M, Bento, L, Balari, AS. Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular. TRANSPLANTATION. 2026; 110(1)DOI:10.1097/TP.0000000000005446. PMID:40524321. IF:5.000(Q1/1D).
01/12/2024
Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study
Abrisqueta-Costa, P, García-Marco, JA, Gutiérrez, A, Hernández-Rivas, JA, Andreu-Lapiedra, R, Arguello-Tomas, M, Leiva-Farré, C, López-Roda, MD, Callejo-Mellén, A, Alvarez-García, E, Loscertales, J. Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study. Cancers. 2024; 16(23)DOI:10.3390/cancers16234004. PMID:39682190. IF:4.400(Q2/3D).